首页> 外国专利> pyruvate kinase M2 PKM2 Biomarker PKM2 for early diagnosis of Renal disorders and their use

pyruvate kinase M2 PKM2 Biomarker PKM2 for early diagnosis of Renal disorders and their use

机译:丙酮酸激酶M2 PKM2生物标志物PKM2用于肾脏疾病的早期诊断及其用途

摘要

The present invention relates to a composition for early diagnosis of kidney diseases, comprising a preparation for measuring the expression level of pyruvate kinase M2 (PKM2) protein in urine. The PKM2 protein of the present invention and a technique utilizing the same may be beneficially used to diagnose and predict, from urine, early diagnosis and disease severity of kidney failure due to diabetes and drugs; due to high sensitivity and specificity, can accurately assess the occurrence of kidney failure; and can effectively detect early signs of kidney failure through a relatively simple method, and thus can be widely used across various fields relating to diagnosis of drug-induced acute kidney failure that may commonly occur in the clinical treatment process, preclinical toxicity testing which is mandatory in new drug development, early detection of diabetic kidney disease, etc.
机译:本发明涉及用于肾脏疾病的早期诊断的组合物,其包括用于测量尿液中丙酮酸激酶M2(PKM2)蛋白的表达水平的制剂。本发明的PKM2蛋白和利用其的技术可有益地用于从尿中诊断和预测由于糖尿病和药物引起的肾衰竭的早期诊断和疾病严重性;由于具有较高的敏感性和特异性,可以准确评估肾功能衰竭的发生;可以通过相对简单的方法有效地检测出肾衰竭的早期征兆,因此可以广泛用于与临床上通常在临床治疗过程中可能发生的药物诱发的急性肾衰竭的诊断有关的各个领域,这是强制性的临床前毒性测试在新药开发,糖尿病肾脏疾病的早期发现等方面

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号